Equities

Mediwelcome Healthcare Management & Technology Inc

Mediwelcome Healthcare Management & Technology Inc

Actions
  • Price (HKD)0.37
  • Today's Change0.00 / 0.00%
  • Shares traded31.20k
  • 1 Year change-47.14%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 05:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Mediwelcome Healthcare Management & Technology Inc's net income fell 5.49% from a loss of 89.20m to a larger loss of 94.10m despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 89.93% to 90.98%.
Gross margin9.74%
Net profit margin-24.91%
Operating margin-23.60%
Return on assets-32.20%
Return on equity-62.99%
Return on investment-60.82%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Mediwelcome Healthcare Management & Technology Inc fell by 58.22m. However, Cash Flow from Investing totalled 16.46m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 75.58m for operations while cash generated from financing totalled 906.00k.
Cash flow per share-0.3825
Price/Cash flow per share--
Book value per share0.5268
Tangible book value per share0.5268
More ▼

Balance sheet in CNYView more

Mediwelcome Healthcare Management & Technology Inc has a Debt to Total Capital ratio of 21.14%, a higher figure than the previous year's 5.57%.
Current ratio1.61
Quick ratio--
Total debt/total equity0.2766
Total debt/total capital0.2114
More ▼

Growth rates in CNY

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-1.03
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.